About Filterlex Medical
Filterlex Medical is a company based in Tel Aviv (Israel) founded in 2015 by Giora Weisz and Eyal Teichman.. Filterlex Medical has raised $16.89 million across 10 funding rounds from investors including European Union, EIC Fund and MedTech Venture Partners. Filterlex Medical offers products and services including CAPTIS. Filterlex Medical operates in a competitive market with competitors including Claret Medical, Emboline, Protembis, Synaptive Medical and Keystone Heart, among others.
- Headquarter Tel Aviv, Israel
- Founders Giora Weisz, Eyal Teichman
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.89 M (USD)
in 10 rounds
-
Latest Funding Round
$7.89 M (USD), Series B
Dec 21, 2021
-
Investors
European Union
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Filterlex Medical
Filterlex Medical offers a comprehensive portfolio of products and services, including CAPTIS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Protects against embolic particles during TAVI and heart procedures.
Unlock access to complete
Unlock access to complete
Funding Insights of Filterlex Medical
Filterlex Medical has successfully raised a total of $16.89M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $7.89 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series B — $7.9M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2021 | Amount | Series B - Filterlex Medical | Valuation | European Union |
|
| Nov, 2021 | Amount | Series A - Filterlex Medical | Valuation |
investors |
|
| Aug, 2021 | Amount | Grant - Filterlex Medical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Filterlex Medical
Filterlex Medical has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, EIC Fund and MedTech Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
MedTech Venture Partners is focused on medical technology investments.
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Filterlex Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Filterlex Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Filterlex Medical Comparisons
Competitors of Filterlex Medical
Filterlex Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Claret Medical, Emboline, Protembis, Synaptive Medical and Keystone Heart, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cerebral vascular protection systems for endovascular procedures are developed.
|
|
| domain | founded_year | HQ Location |
Aortic embolic protection devices are developed for cardiovascular procedures.
|
|
| domain | founded_year | HQ Location |
Manufacturer of cerebral protection device
|
|
| domain | founded_year | HQ Location |
Planning and imaging solutions for neurosurgery are developed.
|
|
| domain | founded_year | HQ Location |
Embolic cerebral protection devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Filterlex Medical
Frequently Asked Questions about Filterlex Medical
When was Filterlex Medical founded?
Filterlex Medical was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Filterlex Medical located?
Filterlex Medical is headquartered in Tel Aviv, Israel.
Is Filterlex Medical a funded company?
Filterlex Medical is a funded company, having raised a total of $16.89M across 10 funding rounds to date. The company's 1st funding round was a Grant of $58.99K, raised on Jun 01, 2016.
What does Filterlex Medical do?
Filterlex Medical was founded in 2015 in Tel Aviv, Israel, within the medical devices sector. An embolic protection device called CAPTIS is developed by the company for use in catheter-based structural heart procedures. The device is positioned in the aorta to lower the risk of stroke and related complications. Co-founders include Giora Weisz and Eyal Teichman, with operations focused on innovation in cardiovascular safety.
Who are the top competitors of Filterlex Medical?
Filterlex Medical's top competitors include Protembis, Synaptive Medical and Emboline.
What products or services does Filterlex Medical offer?
Filterlex Medical offers CAPTIS.
Who are Filterlex Medical's investors?
Filterlex Medical has 3 investors. Key investors include European Union, EIC Fund, and MedTech Venture Partners.